The present invention relates to devices, systems, and methods wherein certain embodiments of the invention include, but are not limited to milling and dispensing, forming and administering, prescribed dosages of one or more combustible medicaments including medical cannabis, dried flower containing tetrahydrocannabinol (THC), dried flower containing cannabidiol (CBD), and hemp dried flower for inhalation and treatment of various conditions and indications.

An aerosol generating device includes a heating chamber arranged to receive a consumable and heat the consumable to generate an inhalable vapour; a consumable picker arranged to engage and retain a consumable, wherein the consumable picker is movable relative to the heating chamber between: a first, external position in which the consumable picker is positioned external to the device; and a second, internal position in which the consumable picker lies within the heating chamber; such that a user may engage a consumable with the consumable picker in the first position and subsequently move the consumable picker to the second position, thereby moving the consumable picker with the retained consumable into the heating chamber for heating. By providing an aerosol generating device including a consumable picker configured in this way, the process of exchanging the consumable is greatly simplified.

Provided is a blister pack for a dry powder inhaler, which dry powder inhaler is configured to deliver a first powder medicament and a second powder medicament different from the first powder medicament. The first and second powder medicaments are contained within blister pockets defined in a strip. A series of blister pockets is defined in the strip, which series extends linearly along the length of the strip. The first and second powder medicaments are contained in blister pockets, e.g. respective blister pockets, of the series. Alternatively or additionally, each of the blister pockets is elongated such as to have a largest dimension parallel with the length of the strip. These measures, either individually or in combination, enable minimizing of the width of the strip in spite of the strip accommodating both the first and second powder medicaments. This, in turn, may enable the depth/thickness of the dry powder inhaler to be minimized, and/or additional space to be provided inside the dry powder inhaler for accommodating, for example, use detection and wireless connectivity electronics for sending use detection data to an external device, such as a smartphone.

The present invention provides a dry powder inhaler comprising: a reservoir containing a dry powder formulation and an arrangement for delivering a metered dose of the medicament from the reservoir; a cyclone deagglomerator for breaking up agglomerates of the dry powder medicament; and a delivery passageway for directing an inhalation-induced air flow through a mouthpiece, the delivery passageway extending to the metered dose of medicament, wherein the formulation comprises an inhalable β.sub.2-agonist having a particle size distribution of d1O<1 μπ.Math.=1-3 μπ.Math., d90=3.5-6 μm and NLT 99% 10 μm and a lactose carrier.

Disclosed herein is a multidrug pain management package to dispense two or more medicaments to treat pain comprising a primary n-polygon, and one or more concentric m-polygons, wherein each side of the n-polygon and m-polygons have at least n or m-medicament chambers capable of holding the two or more medicaments. Also disclosed herein is a multidrug pain management package comprising a disk, wherein the disk is divided into equally spaced regions, and wherein each region has chambers capable of holding medicaments. Also disclosed herein are single formulations to treat pain.

A unit dose container for the containment of an intranasal formulation for use with the POD device.

The present invention provides for the integration of drug dispersion methods into a drug or medicine delivery system. The drug dispersion methods used include shear (e.g., air across a drug, with or without a gas assist), capillary flow or a venturi effect, mechanical means such as spinning, vibration, or impaction, and turbulence (e.g., using mesh screens, or restrictions in the air path). These methods of drug dispersion allow for all of the drug in the system to be released, allowing control of the dosage size. These methods also provide for drug metering, fluidization, entrainment, deaggragation and deagglomeration. The present invention also provides for the integration of a drug sealing system into the device. The drug sealing system provides a way of blocking the migration of drug from one area of the package to another. The drug seal system can also provide a method of tightly containing the drug until the package is opened, of directing airflow through the package and of managing and containing the drug during the package/device manufacturing process.

The aerosol-generating device comprises a device housing (2), a mouthpiece (3) associated to the device housing, a receiving chamber (4) configured to receive from external to the device at least a portion of a sheet of aerosol-forming substrate in a non-rolled form and configured to accommodate a cylindrically shaped of aerosol-forming substrate and a holder (6) for holding the sheet of aerosol-forming substrate. The device further comprises a rolling device (7) for receiving a flat or non-rolled sheet of aerosol-forming substrate and for rolling the sheet of aerosol-forming substrate around the holder from the non-rolled form into a cylindrically shaped aerosol-forming substrate.

An aerosol-generating system comprising: an aerosol-generating article (1), the aerosol-generating article comprising a single metered dose of an aerosol-forming substrate; an airflow pathway (108) arranged between an air inlet (110) and an air outlet (112); an aerosolisation chamber (116) arranged at a location along the airflow pathway (108) such that the airflow pathway passes through at least a portion of the aerosolisation chamber (116); and a flow controller (122, 124) for selectively controlling the flow of air through the airflow pathway (108), the flow controller (122, 124) having an open configuration in which air can flow into and out of the aerosolisation chamber (116) and a closed configuration in which air is substantially prevented from flowing into and out of the aerosolisation chamber (116); wherein the aerosolisation chamber (116) is configured to open to receive only one aerosol-generating article (1) at a time; wherein the aerosolisation chamber (116) is configured to close to contain the aerosol-generating article (1); the aerosol-generating system further comprising a heating element (118, 120) arranged to heat the aerosolisation chamber (116) when an aerosol-generating article (1) is received within the aerosolisation chamber (116); wherein the aerosol-generating system is configured to heat the aerosolisation chamber (116) containing the aerosol-generating article (1) only when the flow controller (122, 124) is in the closed configuration.

An apparatus to provide scent or other substances (e.g., active agent) includes a thin profile delivery apparatus that includes an actuator (e.g., nebulizer) and drive circuit to generate a spray, aerosol or vapor. The apparatus may have a slot to removably a media cartridge that carries the scent or other substances. The apparatus may include two contacts (e.g., buttons), opposed to one another across a dimension of the apparatus. Activation may require both engagement of both contacts, for instance concurrently, or even successive engagement of both contacts, in quick succession. Activation may further require a correct orientation of the apparatus. The apparatus may have a form factor similar to a conventional credit or debit card, and may be pliable or pliably resilient. The delivery apparatus can be used in entertainment (e.g., food or cooking programming), and in healthcare (e.g., control of metabolism).